Journal of Medicinal Chemistry · 2009 · 53 citations · 29 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyNeuropharmacologyAllosteric ModulationAllosteric Modulator DesignCholinergic PharmacologyLigand BindingPotency OptimizationReceptor PharmacologyAcetylcholine Receptor PharmacologyAllosteric Modulator BindingCholinergic Receptor PharmacologyGatingNicotinic Acetylcholine Receptor AgonismNicotinic Receptor PharmacologyPositive Allosteric ModulationPositive Allosteric Modulators
The discovery of a series of pyrrole-sulfonamides as positive allosteric modulators (PAM) of alpha7 nAChRs is described. Optimization of this series led to the identification of 19 (A-867744), a novel type II PAM with good potency and selectivity. Compound 19 showed acceptable pharmacokinetic profile across species and brain levels sufficient to modulate alpha7 nAChRs. In a rodent model of sensory gating, 19 normalized gating deficits. These results suggest that 19 represents a novel class of molecules capable of allosteric modulation of the alpha7 nAChRs.
29
Philippe Séguéla, Jacques I. Wadiche, Kelly Dineley‐Miller et al. · Journal of Neuroscience · 1993 · 1.5K citations · Full text
Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
Ann Olincy, Josette G. Harris, Lynn Johnson et al. · Archives of General Psychiatry · 2006 · 526 citations
Medicine, Neuroscience, Pharmacology +17